EVIO Inc. (EVIO) Taps into Canadian Cannabis Testing Market Ahead of Full Legalization
Global cannabis testing industry expected to reach $1.42 billion by 2021 Leading provider of cannabis testing and scientific research for the regulated cannabis industry operating in North America EVIO on track to double number of testing labs from nine to 18 in 2018, with 11 currently operating facilities Canadian subsidiary EVIO Canada finalizes 50 percent acquisition of Keystone Labs, Inc., a Health Canada-licensed medical cannabis testing facility EVIO Inc. (OTCQB: EVIO) reached a significant milestone in its expansion plans in early May when its new subsidiary, EVIO Canada, announced its acquisition of a 50 percent stake in Keystone Labs, Inc.,…